Gilead Sciences (GILD) Total Debt (2009 - 2026)

Gilead Sciences (GILD) has reported Total Debt for 18 consecutive years, with $28.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt rose 3.27% year-over-year to $28.7 billion; the trailing twelve-month figure through Jun 2026 stood at $28.7 billion (up 3.27% YoY), and the FY2025 full-year result was $27.7 billion, down 2.74% from the prior year.
• Total Debt improved to $28.7 billion in Q2 2026 per GILD's latest filing, from $23.5 billion in the prior quarter.
• Across five years, Total Debt topped out at $29.3 billion in Q2 2023 and bottomed at $23.5 billion in Q1 2026.
• Historically, Total Debt has averaged $27.3 billion across 5 years, with a median of $27.5 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Total Debt dropped 16.03% in 2022, then gained 10.72% in 2025.
• Over 5 years, Total Debt stood at $27.5 billion in 2022, then dropped by 2.61% to $26.8 billion in 2023, then advanced by 6.5% to $28.5 billion in 2024, then retreated by 2.74% to $27.7 billion in 2025, then rose by 3.3% to $28.7 billion in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $28.7 billion, $23.5 billion, and $27.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.